Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 148

1.

Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.

Holloway RG, Shoulson I, Fahn S, Kieburtz K, Lang A, Marek K, McDermott M, Seibyl J, Weiner W, Musch B, Kamp C, Welsh M, Shinaman A, Pahwa R, Barclay L, Hubble J, LeWitt P, Miyasaki J, Suchowersky O, Stacy M, Russell DS, Ford B, Hammerstad J, Riley D, Standaert D, Wooten F, Factor S, Jankovic J, Atassi F, Kurlan R, Panisset M, Rajput A, Rodnitzky R, Shults C, Petsinger G, Waters C, Pfeiffer R, Biglan K, Borchert L, Montgomery A, Sutherland L, Weeks C, DeAngelis M, Sime E, Wood S, Pantella C, Harrigan M, Fussell B, Dillon S, Alexander-Brown B, Rainey P, Tennis M, Rost-Ruffner E, Brown D, Evans S, Berry D, Hall J, Shirley T, Dobson J, Fontaine D, Pfeiffer B, Brocht A, Bennett S, Daigneault S, Hodgeman K, O'Connell C, Ross T, Richard K, Watts A; Parkinson Study Group.

Arch Neurol. 2004 Jul;61(7):1044-53. Erratum in: Arch Neurol. 2005 Mar;62(3):430.

PMID:
15262734
2.

Does levodopa slow or hasten the rate of progression of Parkinson's disease?

Fahn S; Parkinson Study Group.

J Neurol. 2005 Oct;252 Suppl 4:IV37-IV42. Review.

PMID:
16222436
3.

Pramipexole versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke C E, Speller J M, Clarke J A.

Cochrane Database Syst Rev. 2000;(3):CD002259. Review.

PMID:
10908539
4.

Pramipexole. A review of its use in the management of early and advanced Parkinson's disease.

Dooley M, Markham A.

Drugs Aging. 1998 Jun;12(6):495-514. Review.

PMID:
9638397
5.

Treatment of Parkinson's disease: levodopa as the first choice.

Katzenschlager R, Lees AJ.

J Neurol. 2002 Sep;249 Suppl 2:II19-24. Review.

PMID:
12375059
6.

Cabergoline, pramipexole and ropinirole used as monotherapy in early Parkinson's disease: an evidence-based comparison.

Inzelberg R, Schechtman E, Nisipeanu P.

Drugs Aging. 2003;20(11):847-55. Review.

PMID:
12964891
7.
8.

Pramipexole for levodopa-induced complications in Parkinson's disease.

Clarke C E, Speller J M, Clarke J A.

Cochrane Database Syst Rev. 2000;(3):CD002261. Review.

PMID:
10908540
9.

Subcutaneous apomorphine : an evidence-based review of its use in Parkinson's disease.

Deleu D, Hanssens Y, Northway MG.

Drugs Aging. 2004;21(11):687-709. Review.

PMID:
15323576
10.

Pramipexole--a new dopamine agonist for the treatment of Parkinson's disease.

Bennett JP Jr, Piercey MF.

J Neurol Sci. 1999 Feb 1;163(1):25-31. Review.

PMID:
10223406
11.

Cabergoline versus bromocriptine for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KD.

Cochrane Database Syst Rev. 2001;(1):CD001519. Review.

PMID:
11279721
12.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001516. Review.

PMID:
11279718
13.
14.

Parkinson's disease: is the initial treatment established?

Ahlskog JE.

Curr Neurol Neurosci Rep. 2003 Jul;3(4):289-95. Review.

PMID:
12930698
15.

Ropinirole for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2000;(3):CD001516. Review. Update in: Cochrane Database Syst Rev. 2001;(1):CD001516.

PMID:
10908503
16.

Cabergoline for levodopa-induced complications in Parkinson's disease.

Clarke CE, Deane KH.

Cochrane Database Syst Rev. 2001;(1):CD001518. Review.

PMID:
11279720
17.

Initial treatment of early Parkinson's disease: a review of recent, randomized controlled trials.

Biglan K, Holloway RG.

Curr Neurol Neurosci Rep. 2001 Jul;1(4):329-36. Review.

PMID:
11898538
18.

The initial treatment of Parkinson's disease should begin with levodopa.

Weiner WJ.

Mov Disord. 1999 Sep;14(5):716-24. Review.

PMID:
10495031
19.

Dopamine agonist monotherapy in Parkinson's disease.

Clarke CE, Guttman M.

Lancet. 2002 Nov 30;360(9347):1767-9. Review.

PMID:
12480442
20.

A review of pramipexole and its clinical utility in Parkinson's disease.

Biglan KM, Holloway RG.

Expert Opin Pharmacother. 2002 Feb;3(2):197-210. Review.

PMID:
11829733

Supplemental Content

Support Center